Measurement of foveal thickness by optical coherence tomography in adult haemodialysis patients with diabetic nephropathy;Medida del grosor foveolar mediante tomografía de coherencia óptica en pacientes adultos con nefropatía diabética en hemodiálisis

Nefrologia

Volumn 31, Issue 1, 2011, Pages 66-69

  Saavedra, Ingrid Auyanet ^a   Rodriguez L J ^a   Bosch, E ^a   Sanchez A Y ^a   Esparza, N ^a   Lago, M M ^a   Ramirez A ^a   Checa, M D ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Foveolar thickness; Hemodialysis; Macular edema; Optical coherence tomography

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ELECTRIC CONDUCTIVITY; FEMALE; HUMAN; LASER COAGULATION; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RENAL REPLACEMENT THERAPY; RETINA FOVEA; RETINA MACULA EDEMA; TEMPERATURE; ULTRASTRUCTURE; VISUAL ACUITY;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ELECTRIC CONDUCTIVITY; FEMALE; FOVEA CENTRALIS; HUMANS; KIDNEY FAILURE, CHRONIC; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RENAL DIALYSIS; TEMPERATURE; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 79751507505     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Oct.10392     Document Type: Article

References (17)

1. Asencio-Sánchez VM, Gómez-Ramírez V, Morales-Gómez I, Rodríguez Vaca I. Edema macular diabético clínicamente significativo: Factores sistémicos de riesgo. Arch Soc Esp Oftalmol 2008;83:173-6.
2. Matsuo T. Dissapperance of diabetic macular hard exudates after hemodiálisis introduction. Acta Med Okayama 2006;60(3):201-5.
3. Bresnick GH. Diabetic maculopaphy. A critical review highlighting diffuse macular edema. Ophthalmology 1983;90:1301-17.
4. Perkovich BT, Meyers SM. Systemic factors affecting diabetic macular edema. Am J Ophthalmol 1988;105:211-2.
5. British Multicentre Study Group. Photocoagulation in treatment of diabetic maculopathy. Lancet 1975;2:1110-6.
6. British Multicentre Study Group. Photocoagulation for diabetic maculopathy. Diabetes 1983;32:1010-6.
7. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
8. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 4. Int Ophthalmol Clin 1987;27:265-72.
9. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-9.
10. Harbour JW, Smiddy WE, Flynn HW Jr, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405-13.
11. Berman DH, Friedman EA. Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 1994;14:1-5.
12. Freidman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 1995; 26: 202-208.
13. Klein R, Klein BE, Moss SE, et al. The Wiscosin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-15.
14. Ichikawa K, Kanie K, Kaga T. Diabetic macular edema and hemodialysis therapy. Folia Ophtalmol Japonica 2004;55(4):258-64.
15. Tokuyama T, Ikeda K, Sato K. Effects of haemodialysis on diabetic macular leakage. Br J Ophtalmol 2000;84:1397-400.
16. Gracner PD, Gracner T, Hojs R. Optical coherent tomography findings in hemodialysis patients. Klin Monbl Augenheilkd 2008;225(8):713-17.
17. Friedman E, Léxperance F, Brown C, et al. Treating azotemiainduced anemia with erytropoetin improves diabetic eye disease. Kidney Int 2003;64(87):57-63.